Biotechnology Company
Appears in 1 story
Preparing commercial launch of FDA-approved YUVEZZI in Q2 2026
For 240 years, reading glasses have treated presbyopia—the gradual loss of near vision that affects nearly everyone over 45—unchanged since Benjamin Franklin invented bifocals in 1785. Two billion people worldwide still rely on reading glasses today. On January 29, 2026, the FDA approved YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution), the first dual-agent eye drop for presbyopia.
Updated May 23
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
